News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
188,136 Results
Type
Article (6473)
Company Profile (6)
Press Release (181657)
Multimedia
Podcasts (11)
Webinars (1)
Section
Business (50943)
Career Advice (76)
Deals (9020)
Drug Delivery (6)
Drug Development (29149)
Employer Resources (10)
FDA (4659)
Job Trends (4037)
News (92344)
Policy (6807)
Tag
Academia (545)
Accelerated approval (4)
Adcomms (4)
Allergies (33)
Alliances (7603)
ALS (56)
Alzheimer's disease (611)
Antibody-drug conjugate (ADC) (75)
Approvals (4765)
Artificial intelligence (138)
Autoimmune disease (18)
Automation (9)
Bankruptcy (71)
Best Places to Work (4017)
BIOSECURE Act (3)
Biosimilars (39)
Biotechnology (6)
Bladder cancer (68)
Brain cancer (17)
Breast cancer (218)
Cancer (1665)
Cardiovascular disease (107)
Career advice (63)
Career pathing (1)
CAR-T (62)
CDC (1)
Cell therapy (200)
Cervical cancer (16)
Clinical research (25905)
Collaboration (447)
Compensation (249)
Complete response letters (1)
COVID-19 (472)
CRISPR (20)
C-suite (111)
Cystic fibrosis (52)
Data (1754)
Depression (17)
Diabetes (125)
Diagnostics (1644)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (44)
Drug pricing (12)
Drug shortages (2)
Duchenne muscular dystrophy (62)
Earnings (34554)
Editorial (11)
Employer resources (8)
Events (46998)
Executive appointments (380)
FDA (5460)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (393)
Gene editing (43)
Generative AI (3)
Gene therapy (142)
GLP-1 (211)
Government (916)
Grass and pollen (3)
Guidances (98)
Healthcare (5101)
Huntington's disease (11)
IgA nephropathy (21)
Immunology and inflammation (56)
Immuno-oncology (4)
Indications (21)
Infectious disease (534)
Inflammatory bowel disease (65)
Inflation Reduction Act (2)
Influenza (20)
Intellectual property (39)
Interviews (15)
IPO (5482)
IRA (2)
Job creations (353)
Job search strategy (54)
Kidney cancer (7)
Labor market (1)
Layoffs (50)
Leadership (1)
Legal (1180)
Liver cancer (40)
Lung cancer (282)
Lymphoma (119)
Machine learning (4)
Management (4)
Manufacturing (111)
MASH (40)
Medical device (3448)
Medtech (3448)
Mergers & acquisitions (3908)
Metabolic disorders (277)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (46)
Neuropsychiatric disorders (8)
Neuroscience (924)
NextGen: Class of 2025 (1312)
Non-profit (916)
Now hiring (3)
Obesity (112)
Opinion (27)
Ovarian cancer (45)
Pain (46)
Pancreatic cancer (62)
Parkinson's disease (107)
Partnered (2)
Patents (86)
Patient recruitment (69)
Peanut (17)
People (9730)
Pharmaceutical (8)
Phase I (6303)
Phase II (10836)
Phase III (10448)
Pipeline (826)
Policy (24)
Postmarket research (1155)
Preclinical (2762)
Press Release (12)
Prostate cancer (89)
Psychedelics (6)
Radiopharmaceuticals (70)
Rare diseases (181)
Real estate (719)
Recruiting (4)
Regulatory (5636)
Reports (8)
Research institute (530)
Resumes & cover letters (15)
Rett syndrome (7)
RNA editing (1)
RSV (17)
Schizophrenia (39)
Series A (63)
Series B (44)
Service/supplier (2)
Sickle cell disease (27)
Special edition (4)
Spinal muscular atrophy (32)
Sponsored (8)
Startups (513)
Stomach cancer (11)
Supply chain (32)
Tariffs (10)
The Weekly (11)
Vaccines (181)
Venture capital (12)
Weight loss (44)
Women's health (12)
Date
Today (46)
Last 7 days (192)
Last 30 days (910)
Last 365 days (15312)
2025 (8730)
2024 (13308)
2023 (13162)
2022 (15431)
2021 (16149)
2020 (15148)
2019 (12249)
2018 (9157)
2017 (8497)
2016 (8058)
2015 (10106)
2014 (7426)
2013 (5404)
2012 (5995)
2011 (6478)
2010 (5724)
Location
Africa (88)
Alabama (17)
Alaska (1)
Arizona (51)
Arkansas (4)
Asia (9213)
Australia (1464)
California (3849)
Canada (887)
China (337)
Colorado (163)
Connecticut (193)
Delaware (130)
Europe (24073)
Florida (442)
Georgia (107)
Hawaii (1)
Idaho (10)
Illinois (311)
India (10)
Indiana (145)
Iowa (6)
Japan (143)
Kansas (14)
Kentucky (5)
Louisiana (4)
Maine (22)
Maryland (432)
Massachusetts (2905)
Michigan (89)
Minnesota (181)
Missouri (58)
Montana (2)
Nebraska (2)
Nevada (29)
New Hampshire (17)
New Jersey (1103)
New Mexico (6)
New York (984)
North Carolina (415)
North Dakota (3)
Northern California (1653)
Ohio (89)
Oklahoma (4)
Oregon (9)
Pennsylvania (628)
Puerto Rico (3)
Rhode Island (9)
South America (164)
South Carolina (5)
Southern California (1462)
Tennessee (61)
Texas (538)
United States (13225)
Utah (97)
Virginia (82)
Washington D.C. (23)
Washington State (324)
West Virginia (1)
Wisconsin (55)
188,136 Results for "amorchem l p".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Merit Medical Acquires Biolife Delaware, L.L.C.
May 20, 2025
·
15 min read
Earnings
BioNTech’s Ambitious PD-L1/VEGF Plans Currently Rely on Chinese Manufacturing
BNT327, a PD-L1/VEGF therapy, is still currently being manufactured in China, but BioNTech is working to establish a diversified supply chain, executives said during the company’s Q1 investor call.
May 5, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC
May 23, 2025
·
8 min read
Press Releases
FDA’s Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI’s Multikine to Address a Major Unmet Need in PD-L1 Negative Cancer Patients
June 18, 2025
·
5 min read
Press Releases
Bora Biologics Expands San Diego Facility for 2000L+ Scale Biologics Manufacturing, Boosting CDMO Capacity
May 20, 2025
·
5 min read
Press Releases
Centinel Spine® Continues to Innovate in Lumbar Total Disc Replacement through the Release of New prodisc® L Instrumentation
June 6, 2025
·
5 min read
Pharm Country
Purdue Pharma L.P. Awards Grant for Investigator-initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Purdue Pharma L.P. (“Purdue”) announced today that the Company has awarded an investigator-initiated research (IIR) grant to a team of researchers at The University of New Mexico (UNM) for the evaluation of nalmefene hydrochloride (HCl) injection 2mg/2mL (1mg/1mL) in the emergency department setting.
March 27, 2024
·
7 min read
Policy
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. have entered into a binding settlement agreement and mutual release settling ongoing litigation.
December 1, 2023
·
6 min read
Press Releases
BRENIG THERAPEUTICS ANNOUNCES APPOINTMENTS OF DAVID L. LUCCHINO AS CEO AND TIEN DAM, M.D., AS CHIEF MEDICAL OFFICER, EXPANDS PIPELINE
July 11, 2025
·
4 min read
Press Releases
Volastra Therapeutics Announces Appointment of David P. Southwell as Chief Executive Officer
May 27, 2025
·
2 min read
1 of 18,814
Next
